Status:
UNKNOWN
Iran- Premature Coronary Artery Disease
Lead Sponsor:
Isfahan University of Medical Sciences
Collaborating Sponsors:
Iran Ministry of Health, Treatment, and Medical Education
Conditions:
Coronary Vessels
Eligibility:
All Genders
Up to 70 years
Brief Summary
This case-control study will be conducted all over the country (in Persian, Kurd, Azari, Arab, Lor, Bakhtiari, Baluch, Turkman, Qashqai, Gilak and in Muslims, Christians, Jewish, and Zoroastrian). the...
Detailed Description
Coronary heart disease (CHD) is one of the most important causes of mortality in the world and accounts for up to 30% of deaths. CHD is also prevalent in Iran and in some studies, the prevalence of th...
Eligibility Criteria
Inclusion
- Men and women less than 60 and 70 years respectively
- Ethnicity
- Coronary artery stenosis more than 75% (or left-main stenosis more than 50%) or patients with normal angiography
Exclusion
- patients with past medical history of CABG or documented coronary stenosis
Key Trial Info
Start Date :
August 25 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04414176
Start Date
August 25 2018
End Date
December 30 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isfahan Cardiovascular Research Institute
Isfahan, Iran, 8158388994